Back
Reviva Pharmaceuticals Holdings 10K Form
Buy
58
RVPH
Reviva Pharmaceuticals Holdings
Last Price:
$1.79
Seasonality Move:
-10.48%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RVPH News And Ratings
See the #1 stock for the next 7 days that we like better than RVPH
RVPH Financial Statistics
Sales & Book Value
Annual Sales: | -- |
---|---|
Cash Flow: | $-4.2M |
Price / Cash Flow: | 0 |
Annual Sales: | $-0.30 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -1.09000 |
---|---|
Net Income (TTM): | $-33M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | 0% |
Reviva Pharmaceuticals Holdings Earnings Forecast
Key Reviva Pharmaceuticals Holdings Financial Ratios
-
The Interest Expense is -0.03% of Operating Income.
-
Per Share Earnings over the last 5 years have been positive in 1 years.
Reviva Pharmaceuticals Holdings Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | RVPH |
Website: | revivapharma.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
RVPH Technical Analysis vs Fundamental Analysis
Buy
58
Reviva Pharmaceuticals Holdings (RVPH)
is a Buy
Is Reviva Pharmaceuticals Holdings a Buy or a Sell?
-
Reviva Pharmaceuticals Holdings stock is rated a BuyThe current Reviva Pharmaceuticals Holdings [RVPH] share price is $1.86. The Score for RVPH is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.